Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: March 6, 2025
Reporting Period: This filing reports on events occurring on March 6, 2025, specifically regarding upcoming investor presentations.
Financial Metrics
This Form 8-K does not contain specific financial statements, revenue figures, profit data, cash flow, margins, debt levels, or liquidity metrics. The filing serves as a disclosure of upcoming communications rather than a financial results report.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing discloses that executive officers have scheduled upcoming presentations to investors and analysts.
Guidance, Outlook, and Management Commentary
Investor Presentations: Executive officers intend to use the material filed as Exhibit 99.1 (OrthoPediatrics Corp. Investor Presentation dated March 2025) for upcoming meetings with investors and analysts.
Regulatory Status: The information provided in Item 7.01 and Exhibit 99.1 is furnished pursuant to Regulation FD and is not deemed "filed" for purposes of Section 18 of the Exchange Act, nor is it incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the content of Exhibit 99.1 (Investor Presentation dated March 2025) for specific financial guidance or operational updates, as this 8-K only references the presentation.
- Confirm the dates and details of the upcoming investor and analyst presentations mentioned by management.
- Note that the information in this filing is not legally "filed" under Section 18 of the Exchange Act, limiting liability for forward-looking statements contained in the referenced presentation.